Kyverna Therapeutics KYTX
NASDAQ KYTX
$5.12 +0.04 (+0.79%)
At close: Nov 11, 2026 · 4:00 PM EST

Kyverna Therapeutics (KYTX) Interest Paid (2023 - 2026)

Updated

Analysis

Kyverna Therapeutics (KYTX) Interest Paid (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Paid (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -1.78 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 283.00 Mn
10 Kyverna Therapeutics 312.78 Mn -573.60 Mn - 573,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 573,000.00
Mar 31, 2026 568,000.00
Dec 31, 2025 370,000.00
Sep 30, 2025 8,000.00
Jun 30, 2025 18,000.00
Mar 31, 2025 19,000.00
Dec 31, 2024 27,000.00
Sep 30, 2024 33,000.00
Jun 30, 2024 38,000.00
Mar 31, 2024 44,000.00
Dec 31, 2023 47,000.00
Sep 30, 2023 50,000.00
Jun 30, 2023 46,000.00
Mar 31, 2023 44,000.00
API Access

Kyverna Therapeutics Interest Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-paid&ticker=KYTX&period=max&api_key=YOUR_API_KEY